Compare Bundamedik Tbk (BMHS) vs Cipta Sarana Medika Tbk. (DKHH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Cipta Sarana Medika Tbk. — how do they compare? Bundamedik Tbk trades at Rp188 (market cap 1.63T, 725.9K 24h volume), while Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 14.05M 24h volume). The key difference: Bundamedik Tbk is far larger — about 10.1× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (14.05M versus 725.9K). Which is the better fit depends on your goals.
| BMHS | DKHH | |
|---|---|---|
Market Cap | 1.63T | 160.67B |
Volume | 725.9K | 14.05M |
Lot | 7.26K | 140.49K |
Turnover | 135.94M | 899.67M |
Average Price | 187.26 | 64.04 |
Value | 135.94M | 899.67M |
Indicative Equilibrium Price | 188 | 64 |
Indicative Equilibrium Volume | 1 | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →
